🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "targeted action to address household expense challenges" in next month's Budget.

During an interview with the BBC, she stated that reducing price rises is a shared task of both the administration and the central bank.

The United Kingdom's price growth is forecast to be the most elevated among the G7 advanced economies this year and the following year.

Possible Energy Cost Measures

It is understood the administration could intervene to bring down utility costs, for instance by cutting the present 5% rate of value-added tax charged on energy.

A further option is to cut some of the regulatory levies currently included in bills.

Fiscal Limitations and Analyst Expectations

The government will receive the next assessment from the official forecaster, the OBR, on Monday, which will clarify how much scope there is for these actions.

The consensus from most analysts is that Reeves will have to declare higher taxes or expenditure reductions in order to fulfill her voluntary borrowing rules.

Earlier on the same day, estimates showed there was a £22 billion gap for the chancellor to address, which is at the lower end of expectations.

"It is a shared task between the central bank and the government to bear down further on some of the causes of inflation," the Chancellor informed reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Issues

While a great deal of the focus has been on likely tax increases, the Treasury chief said the latest information from the fiscal watchdog had not altered her vow to campaign commitments not to raise tax levels on earnings tax, sales tax or National Insurance.

She blamed an "unpredictable world" with increasing geopolitical and commercial issues for the fiscal tax moves, probably to be directed on those "wealthiest."

Global Trade Tensions

Commenting on worries about the UK's economic relations with China she said: "The UK's security interests invariably are paramount."

Last week's declaration by China to increase export controls on rare earths and other resources that are essential for advanced tech production led US President Donald Trump to propose an further 100% tariff on goods from the Asian country, increasing the risk of an all-out trade war between the two economic giants.

The US Treasury Secretary described the Chinese move "economic coercion" and "a international production power grab."

Questioned on accepting the US offer to join its dispute with China, the Chancellor said she was "deeply worried" by Chinese measures and called on the Chinese government "to avoid restrictions and limit trade."

She said the action was "damaging for the global economy and causes additional obstacles."

"I believe there are sectors where we must confront Chinese policies, but there are also valuable chances to trade with China's economy, including financial services and other areas of the economy. We've got to achieve that balance correct."

The chancellor also confirmed she was working with international partners "on our own essential resources approach, so that we are reduced dependence."

Health Service Medicine Costs and Funding

The Chancellor also admitted that the cost the National Health Service spends on medicines could rise as a result of current talks with the Trump administration and its drugs companies, in exchange for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either pausing or abandoning operations in the United Kingdom, with some attributing the low prices they are getting.

Last month, the Science Minister said the price the health service pays for medicines would have to go up to prevent companies and pharmaceutical investment leaving the United Kingdom.

Reeves stated to media: "We have seen due to the pricing regime, that clinical trials, recent pharmaceuticals have not been provided in the UK in the way that they are in other continental states."

"Our aim is to guarantee that patients receiving treatment from the National Health Service are can obtain the top critical medicines in the globe. And so we are looking at all of that, and... seeking to secure increased funding into Britain."